A 73-year-old woman was admitted to our hospital for a scheduled percutaneous transcatheter balloon valvuloplasty of a stenotic tricuspid bioprosthesis. The patient had a history consistent with exertional dyspnea, abdominal distension, and edema of the lower extremities resistant to diuretic treatment over the previous few months. Forty-three years prior, she underwent aortic valve replacement...

Introduction: Since its introduction in 1984, mitral balloon valvuloplasty became the treatment of choice for mitral stenosis. After a successful procedure, the major event on long follow up is restenosis which treatment is discussed between surgery or redo mitral balloon valvuloplasty (mbv). Methods: Our study was a retrospective and descriptive one. In Hedichaker hospital between 1998 and 200...

standard' for the assessment of the early results of percutaneous mitral commissurotomy, especially when a transseptal approach is used with its inherent risk of inter-atrial shunt [6]. Finally, the problem of cost is addressed in this study. Overall, we should remember that the duration of hospitalization was short (24 h) and that re-use of balloons is commonplace in developing countries. In f...

Left ventricular assist devices and percutaneous valve interventions have radically changed the treatment of advanced heart disease and minimized surgical morbidity in patients with end-stage heart failure who would not survive conventional surgery. We describe a successful approach to the simultaneous placement of a percutaneous left ventricular assist device and mitral valvuloplasty in a deco...